Phospholipase C-b1 (PLC-b1) is a rate-limiting enzyme implicated in postnatal-cortical development and neuronal plasticity. PLC-b1 transduces intracellular signals from specific muscarinic, glutamate and serotonin receptors, all of which have been implicated in the pathogenesis of schizophrenia. Here, we present data to show that PLC-b1 knockout mice display locomotor hyperactivity, sensorimotor gating deficits as well as cognitive impairment. These changes in behavior are regarded as endophenotypes homologous to schizophrenialike symptoms in rodents. Importantly, the locomotor hyperactivity and sensorimotor gating deficits in PLC-b1 knockout mice are subject to beneficial modulation by environmental enrichment. Furthermore, clozapine but not haloperidol (atypical and typical antipsychotics, respectively) rescues the sensorimotor gating deficit in these animals, suggesting selective predictive validity. We also demonstrate a relationship between the beneficial effects of environmental enrichment and levels of M1/M4 muscarinic acetylcholine receptor binding in the neocortex and hippocampus. Thus we have demonstrated a novel mouse model, displaying disruption of multiple postsynaptic signals implicated in the pathogenesis of schizophrenia, a relevant behavioral phenotype and associated gene-environment interactions.
Introduction
The cerebral cortex, which has been suggested to malfunction in subjects with schizophrenia, 1,2 requires a tightly regulated genetic program modulated by activity-dependent plasticity for appropriate development. Phospholipase C-b1 (PLC-b1), a phosphodiesterase, has been shown to be important in postnatal-cortical development and plasticity [3] [4] [5] and is known to regulate key G protein-coupled signaling pathways in the human cortex. 6 Significantly, a recent microarray study has shown decreased levels of PLCb1 in the dorsolateral prefrontal cortex of subjects with schizophrenia (personal communication; Elizabeth Thomas), suggesting that expression of this important signaling protein may be altered in the cortex of subjects with this disorder.
PLC-b1 acts by cleaving phosphoinositide bi-phosphate into the ubiquitous second messenger signaling molecules diacylglycerol (DAG) and inositol triphosphate (IP3). DAG can then stimulate protein kinase C, facilitating specific protein phosphorylation, while IP3 binds to its receptor which mobilizes intracellular stores of Ca 2 þ , an event known to be important for specific aspects of cortical development and plasticity. 7, 8 PLC-b1 can therefore signal through multiple pathways that are known to respond to serotonergic, 9 ,10 dopaminergic, 11,12 cholinergic 9,13 or glutamatergic neurotransmission, 3, 9 which have been implicated in the pathogenesis of schizophrenia.
Schizophrenia has an approximately 50% concordance rate in monozygotic twins and 1% prevalence in the general population. These and other findings suggest that this brain disorder arises from a genetic predisposition affecting neurodevelopmental processes, combined with exposure to environmental risk factors. 14 The complexity of the underlying physiological basis is highlighted by the multitude of pathways that have been implicated in pathogenesis including those involving dopaminergic, 15, 16 serotonergic, 17 ,18 muscarinic [19] [20] [21] [22] and glutamatergic signaling pathways. [23] [24] [25] It is, therefore, significant that PLC-b1 represents a point of convergence for these signaling pathways and that levels of the protein have been shown to be altered in the cortex of chronic schizophrenic patients, increasing in the prefrontal cortex and decreasing in the superior temporal gyrus. 26 The outcomes of disrupted PLC-b1 signaling can be studied in PLC-b1 knockout (KO) mice, 9 which have been shown to have abnormal cortical maturation including aberrant barrel formation in the somatosensory cortex 3 as well as disrupted synapse formation and dendritic spine morphology. 27 Behaviorally, spatial memory deficits have been identified 28, 29 but a more complete behavioral phenotype has not yet been established. Therefore, in this study we present our characterization of the phenotype of the PLC-b1 KO mice, including behavioral paradigms assessing endophenotypes representative of aspects of schizophrenia symptomatology, 30, 31 under different environmental and pharmacological conditions. In addition, we have examined whether key markers in the dopaminergic, serotonergic and cholinergic pathways, which have been shown to be altered in the cortex of subjects with schizophrenia, 17, [32] [33] [34] [35] [36] [37] [38] are altered by the PLC-b1 mutation or environmental stimulation.
Methods
Animals PLC-b1 KO mice 9 were bred from mice heterozygous for the null mutation on an SV129/C57Bl6 background strain. A preliminary behavioral screen established basic visual, oral and sensory abilities of the KO mice. Genotype was determined by PCR. 3, 9 At 4 weeks, PLC-b1 KO mice and littermate controls (wild-type or heterozygous mice) were weaned and housed in groups of 3-7, with food and water ad libitum. To improve their well-being, in addition to standard mouse chow, sunflower seeds were scattered throughout the cage, facilitating independent feeding for the smaller mice post-weaning and providing opportunity for foraging behaviors. This improved health in the majority of mice and all mice subjected to behavioral testing were in good physical condition, as demonstrated by the control measures of these tests. The mice were maintained on a 12-h light/dark cycle. Testing was performed blind to the genotype. All procedures had the approval of the Institute's Animal Ethics Committee.
Environmental enrichment
At weaning, mice were separated into standard housed (SH) or environmentally enriched (EE) cages. SH mice were treated as described above, housed in standard mouse cages (34 Â 16 Â 16 cm) with basic nesting materials. EE mice were housed in larger cages (40 Â 28 Â 18 cm) with access to running wheels, various toys, tunnels, housing and platforms that were changed weekly to maintain novelty. Additionally, 5 days per week, the mice were placed into a 'super-enrichment chamber'. This consisted of a large box (94 l volume), filled with items, which varied in texture and shape, encouraging the creation of new spatial maps and providing novel cognitive challenges. Mice were given 1 h to explore the chamber before being returned to their home cage. Four weeks of post-weaning enrichment or standard housing was completed before behavioral testing.
Morris water maze
The hippocampal-dependent version of the Morris water maze (MWM) was used to assess spatial memory. MWM was performed in a dark-green circular tank (88 cm in diameter), filled with water made opaque with 4 l of milk (22711C). The tank was divided into four quadrants with schematic cues located on the side of the tank in each quadrant (platform, opposite platform, left and right). Before training, all mice were habituated to the water and the presence of a submerged platform with three preliminary trials. Mice (n = 9-15 per group) were trained to find a submerged platform for four trials per day on 4 consecutive days and tested for recall in a single probe trial on the 5th day. The position of the platform varied between mice to avoid quadrant bias and starting positions were randomized. In each of the training trials the mouse was given 60 s to locate the platform, after which it was guided to the platform, if it did not find it before this time. For the probe trial, the platform was unavailable. Maze behavior and search strategy, during this probe trial, were recorded and scored using the Noldus Ethovision (Wageningen, the Netherlands) automated tracking system (v3).
Locomotor activity
Photo-beam activity arenas (E63-10, TruScan Coulbourn Instruments, Allentown, PA, USA), consisting of two sensor rings at different heights, were used to monitor the exploratory activity of mice in the horizontal and vertical plane by detecting the number of beam breaks at a spatial resolution of 0.76 cm. Mice (n = 14-24 per group) were placed in locomotor arenas situated in sound-attenuating dimmed behavioral test rooms for 15 min sessions on 5 consecutive days; 4 habituation days to minimize confounds such as stress and anxiety induced by the novelty of the environment, and the subsequent test trial. Distance moved, time spent moving and velocity were quantified using the TruScan 2.0 software (Coulbourn Instruments).
Acoustic startle response and prepulse inhibition of acoustic startle Acoustic startle response (ASR) and prepulse inhibition (PPI) testing were performed as described previously. 39 Briefly, both behaviors were assessed using automated SR Lab startle equipment (San Diego Instruments, San Diego, CA, USA). Each unit consisted of a Plexiglas cylinder mounted upon a platform underneath which a sensitive piezo-electric sensor measured movement. Startle response to pulse was measured on SR lab software. Mice (n = 10-24 per group) were placed into the cylinder and the platform slotted into a sound-attenuating console with roofmounted speakers. Background 'white noise' (70 dB) was transmitted through the speakers before, during and after prepulse and pulse stimuli. Each session consisted of 100 trials where the first and the last ten trials consisted of 'pulse only' startle inducing stimuli of 115 dB lasting 40 ms (P115 trials, Block 1 and 4 respectively). The central 80 pulses were a pseudorandomized program of 20 P115 trials (startle only, Blocks 2 and 3), ten measured recordings with no stimulus to measure baseline movement, and 5 Â 10 115 dB pulses preceded by a prepulse of 2, 4, 8, 12 or 16 dB above the baseline 'white noise' to measure the animals' capacity for sensorimotor gating. In these instances, the prepulse preceded the pulse by 100 ms and lasted for 20 ms. One day before testing, the mice were habituated to the chamber by the same pulse alone and prepulse þ pulse program. Percent inhibition was calculated by dividing the difference between the average startle response and the median of the relevant prepulse þ pulse group of ten startle responses, by the average startle response of the central 20 pulse alone trials.
Drug treatment
Clozapine, haloperidol or saline were administered intraperitoneally. Acute dosages were administered 20 min before the PPI session. Each mouse underwent five sessions, four drug treated and one saline control. Haloperidol (Serenace, Searle Laboratories, Crows Nest, NSW, Australia) and clozapine (Sigma Chemical Co., St Louis, MO, USA) were administered at concentrations of 1 and 5 mg/kg. 40 Treatments were randomized and mice (n = 10-12 per group) were allowed to recover from the drug treatment for a minimum of 7 days in between treatments, each mouse undergoing behavioral testing under the influence of clozapine 1 and 5 mg/kg, haloperidol 1 and 5 mg/kg and saline. The 1 mg/kg doses of each drug had no statistically significant effects and thus only 5 mg/kg data are presented here.
Tissue collection and processing Animals were killed by cervical dislocation, and whole brains were dissected, immersed in Tissue Tek OCT (Sakura Finetek, Tokyo, Japan), frozen and stored at À801C. Serial coronal sections, 14 mm, were cut at À201C on a Leica CM 3050 S cryostat (Leica, Frankfurt, Germany), mounted onto gelatin/chrome alum subbed glass slides and stored at À801C. Sections between Bregma À1.46 and À2.06 were selected for in situ radioligand binding and autoradiography. ]YM-09151), washed 2 Â 2 min in buffer (41C), rinsed in ice-cold H 2 O and then dried under a stream of cool air. All slides were fixed in a desiccator containing paraformaldehyde vapor, and apposed to Fuji BAS tritium-sensitive phosphorimaging plates (Fuji Photo Film Co, Tokyo, Japan). Following a suitable exposure, plates were read using the Fujifilm BAS-5000 Bioimaging analyzer (Fuji Photo Film Co) and densities were assessed using the AIS image analysis system, normalized using [ Coronal sections were chosen to include a hippocampal cross-section, in addition to the most caudal area of the CPu. Within these sections, brain regions were selected for analysis based upon the binding pattern of distinct radioligands. Where no separate cortical or hippocampal regions were delineated, this was because binding was consistent across the regions, making an arbitrary separation (in the absence of a density change) inaccurate.
For [ 3 H]pirenzepine binding, cortex was defined as somatosensory, auditory and visual cortex, and was delineated by the boundaries of the lateral parietal association cortex and the ectorhinal cortex.
41 CA1
consisted of the oriens layer, the pyramidal layer and the stratum radiatum of the hippocampus. The dentate gyrus included both the polymorphic and the granular layers and the striatum assessed was the most caudal section of the caudate putamen (illustrated in Figure  5a YM-09151, the hippocampus was assessed as a whole (Figure 6a ). For all radioligand binding, the most caudal section of the striatum was used (Figure 7a ).
Statistics
Autoradiographic analyses and the MWM behavioral task were performed upon PLC-b1 WT and KO mice. Data analysis was performed by two-way analysis of variance (ANOVA) with genotype and environment as main factors, with in-built post hoc tests (Tukey's t-test or Rank Sum analysis) to isolate the source of variation, following establishment of a significant main effect.
PPI and locomotor behaviors were performed upon WT, heterozygote (Het) and KO PLC-b1 mice. PLC-b1 heterozygous mice have shown no observable phenotype at either the behavioral or molecular level. Nonetheless, SH WT and Het data were initially assessed separately with no differences between the genotypes observed. Subsequently, Het and WT mice were grouped and statistically analyzed. PPI with drug treatment was analyzed by repeated measures ANOVA.
Results
PLC-b1 KO mice display spatial memory deficits that are not altered by environmental enrichment PLC-b1 KO mice and WT littermates that received either SH or environmental enrichment were assessed on the MWM (Figure 1 ). WTSH and WTEE mice spent more time in the target quadrant than the other quadrants ( Figure 1b ; F (1,32) = 8.4, P < 0.001 for WTSH and F (3, 36) = 11.9, P < 0.001 for WTEE). KOSH and KOEE animals showed no preference for the quadrant in which the platform was located. KOSH mice also displayed decreased frequency of crossing over the platform (Figure 1c ; main effect of genotype, F (1,41) = 68.5, P < 0.001) and increased latency ( Figure  1d ; F (1,41) = 53.5, P < 0.01).
Enrichment had no effect upon MWM performance, with WTSH and EE animals showing equal preference for the target quadrant, while KOSH and EE animals spent equal amounts of time across all quadrants ( Figure 1b ). This deficit was not due to impaired movement as control measures of distance moved ( Figure 1e ) and velocity during the probe trial ( Figure  1f ) reveal no significant difference between groups.
PLC-b1 KO mice display a hyperactive phenotype, which is inverted by environmental enrichment Assessment of locomotor activity showed that KOSH mice exhibit substantial hyperactivity in comparison to WTSH. Environmental enrichment not only modulated this phenotype, but completely inverted it so that KOEE mice exhibited a hypoactive phenotype Figure 1 Morris water maze. Performance of phospholipase C-b1 knockout (PLC-b1 KO) mice housed in different environmental conditions. The Morris water maze was divided into four quadrants; P-the quadrant in which the platform was located, OP-the quadrant opposite to the platform, L-the quadrant left of 'P' and R-the quadrant right of 'P' (a). Decreased crossing over the platform location (c; P < 0.001) and decreased latency to the platform location (d; P < 0.001) indicate impaired spatial memory in the PLCb1 KO mice. This impairment in standard housed (SH) KO mice, is not altered by an enriched environment (EE). Wildtype (WT) mice preferentially spent time in the quadrant containing the platform (P), compared with the left (L), right (R) and opposite platform (OP) quadrants (b; WTSH P < 0.001, F (3,32) = 8.4 and WTEE P < 0.001, F (3,36) = 11.9). Conversely, the KO mice, both SH and EE, showed no significant preference for quadrant. Accordingly, a significant genotype effect was observed for duration in the target quadrant (P < 0.001). Control measures of distance traveled (e) and velocity (f) revealed no significant differences between groups. ***P < 0.001.
( Figure 2a ). Enrichment did not affect locomotion in the WT mice. Two-way ANOVA revealed significant differences in the distance moved (Figure 2a ; main effect of genotype F (1,28) = 4.4, P < 0.05, main effect of environment F (1,28) = 28.2 P < 0.001 and genotype-environment interaction F (1,28) = 25.4, P < 0.001). There was no main effect of genotype for velocity (Figure 2b) , although we observed a main effect of environment (F (1,28) = 18.3, P < 0.001) and a genotype-environment interaction (F (1,28) = 16.2, P < 0.001).
PLC-b1 KO mice have a reduced ASR
The startle response to acoustic pulses of 115 dB was measured in WT and KO mice under different environmental and pharmacological conditions. PLCb1 KO mice show significantly diminished levels of acoustic startle, when compared to WT littermates (Figure 3a ; main effect of genotype, F (1,34) = 45.2, P < 0.001). Environmental enrichment had a significant effect upon startle response (main effect of environment F (1,34) = 10.8, P < 0.001). No effect by block was observed for all groups, illustrating minimal habituation across the testing period, allowing blocks to be grouped for further analysis. When comparing average startle responses, a significant effect of genotype was again observed (F (1,67) = 12.9, P < 0.001) and a trend toward significance for the effect of environment (F (1,67) = 3.5, P = 0.065). Furthermore, post hoc tests indicate that KOSH mice show lower average startle responses than their WT littermates (P < 0.001). Enrichment significantly decreases the startle response of WT mice (P < 0.01), but does not significantly affect the average response of KO mice.
Based on our evidence for behavioral endophenotypes of relevance to schizophrenia, we performed pharmacological studies to assess predictive validity. Saline-treated (vehicle) and drug-treated (clozapine and haloperidol) mice displayed a lack of habituation across the testing period with no difference observed between blocks. We again observed a significant effect of genotype upon the average startle response, as well as an effect of drug administration (Figure 3b ; twoway ANOVA; effect of genotype F (1,57) = 7.7, P < 0.01 and effect of drug F (2,57) = 23.7, P < 0.001). Salineinjected KO mice had a significantly lower startle amplitude than their WT littermates (P < 0.05). Clozapine significantly attenuated the startle response of WT and KO mice (Figure 3b ; main effect of clozapine F (1,34) = 48.3, P < 0.001), with a genotype Â drug interaction observed (F (1,34) = 7.0, P < 0.05). Clozapine had significant effects upon both WT (P < 0.001) and KO (P < 0.05) startle. Haloperidol had no effect on startle.
PLC-b1 KO mice show a deficit in PPI that is rescued by environmental enrichment and by clozapine, but not haloperidol treatment Following establishment of the baseline acoustic startle, we then assessed PPI of acoustic startle, a measure of sensorimotor gating abilities. The PLC-b1 KO mice show a robust PPI deficit (Figure 4 ; main effect of genotype F (1,335) = 18.2, P < 0.001). Environmental enrichment significantly increased PPI (Figure 4a ; main effect of environment F (1,335) = 37.5, P < 0.001). In addition, environmental enrichment rescued the deficits observed in the PLC-b1 KO mice, as shown by a significant interaction between environmental conditions and genetic factors (F (1,335) = 5.1, P < 0.05). This effect was dependent upon the intensity of the prepulse, as shown by a genotype Â environment Â prepulse interaction (F (4,335) = 2.9, P < 0.05). Repeated measures analysis of the saline treatment replicated the original finding of a genotype effect with KO-saline mice showing a PPI deficit relative to the WT-saline littermates (Figure 4b ; F (1,35) = 6.0, P < 0.05).
Haloperidol treatment significantly increased PPI (Figure 4b ; F (4,335) = 9.5, P < 0.01). This effect was comparable in WT and KO mice, and thus KOhaloperidol-treated mice retain their PPI deficit relative to WT-haloperidol-injected animals (F (1,35) = 5.9, P < 0.05).
Clozapine treatment significantly increased PPI in WT and KO mice (Figure 4c ; main effect of clozapine F (1,34) = 9.2, P < 0.01) with a significant interaction between clozapine administration and prepulse intensity (F (1,34) = 6.2, P < 0.001). It also selectively rescued the PPI deficit in PLC-b1 KO mice, as demonstrated by a clozapine Â genotype Â prepulse interaction (Figure 4d ; F (1,34) = 3.0, P < 0.05). The interaction between prepulse and clozapine administration was statistically stronger for KO mice (F (1,34) = 4.0, P < 0.01), than it was for WT littermates (F (1,34) = 2.9, P < 0.05).
KO mice show region-specific [
3 H]pirenzepine binding deficits that are rescued by environmental enrichment To further investigate the possibility that changes in muscarinic cholinergic signaling may be involved Distance Velocity
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7500 5000 2500 0 * * * * * * * * * * * * * * 1500 1000 500 0 * * * * * * * * distance moved/time total distance (coordinate changes) a b Figure 2 Photobeam arena. Locomotor behavior of phospholipase C-b1 knockout (PLC-b1 KO) mice housed under different environmental conditions. Standard housed (SH) PLC-b1 KO mice displayed hyperactivity as evidenced by greater total distance moved during the 15 min time period (a; P < 0.01) in addition to higher velocity (b; P < 0.05). Environmental enrichment (EE) had no effect upon the locomotor behavior of wild-type (WT) mice, but inverted KO behavior leading to a hypoactive phenotype compared with WTEE mice reflected again in distance moved (P < 0.001) and velocity (P < 0.001). *P < 0.05, **P < 0.01, ***P < 0.001.
in both the deficits and subsequent environmental enrichment-driven rescue of motor and sensorimotor behavior, pirenzepine binding was assessed. A consistent decrease in startle was observed for WTEE mice compared with their SH littermates (repeated measures analysis of variance (ANOVA) P < 0.01); however, no effect of EE was detected for the KO animals. Neither WT nor KO mice in SH or EE conditions showed habituation to the startle stimulus across the testing period (Block 1 (B1), Block2 (B2), Block3 (B3) or Block4 (B4)). (b) Saline-injected PLC-b1 KO mice had significantly reduced startle when compared with their WT littermates (P < 0.001). Haloperidol (HAL) was found to have no effect on startle relative to saline control-injected mice. Two-way repeated measures ANOVA revealed significantly decreased startle response following clozapine (CLOZ) treatment (P < 0.0001), and a drug Â genotype interaction (P = 0.012). *P < 0.05, **P < 0.01, ***P < 0.001.
tions ( Figure 5b ; F (1, 14) = 5.7, P < 0.05) with KOSH animals showing a significant reduction in [ 3 H]pirenzepine binding in comparison to WTSH (P < 0.05). There was no effect of environmental enrichment on WT mice; however, there was a suggestive trend for KOEE to show increased binding in comparison to KOSH (P = 0.07). In the CA1 region of the hippocampus, we again observed an interaction between genotype and environmental conditions (Figure 5c ; F (1,15) = 7.5, P < 0.05). While no significant changes were observed between WTSH and KOSH mice, enrichment significantly increased binding levels in the KOEE group relative to KOSH (P < 0.05). There was no significant change between WTSH and WTEE. Similarly, within the dentate gyrus, there was a significant gene-environment interaction (Figure 5d ; F (1,15) = 4.6, P < 0.05) with KOSH mice exhibiting a decrease in [ In order to assess the specificity of these muscarinic acetylcholine receptor changes, we also compared specific serotonin (5-HT 2A ) and dopamine (D2) receptors using autoradiography. [ 3 H]ketanserin binding to 5-HT 2A receptors is observed throughout the neocortex, hippocampus and striatum as expected. Two-way ANOVA revealed no significant differences between groups, either by genotype or by housing conditions in the CPu (F (1, 20) = 0.596, P = 0.451 for genotype, and F (1, 20) = 0.0681, P = 0.797 for environment), layer 2/3 of the cortex (F (1, 20) = 0.000638, P = 0.98 for genotype, and F (1, 20) = 2.041, P = 0.171 for environment), cortical layer 4 (F (1, 20) = 0221, P = 0.644 for genotype, and F (1, 20) = 0.0364, P = 0.851 for environment), cortical layer 5/6 (F (1, 20) = 0.000582, P = 0.981 for genotype, and F (1, 20) = 0.716, P = 0.409 for environment) and hippocampus (F (1, 20) = 0.756, P = 0.397 for genotype, and F (1, 20) = 2.796, P = 0.113 for environment) (Figure 6) .
[ 3 H]YM-09151 binding to D2-like receptors was greatest in the striatum, with only low levels of binding observed in the cortex and hippocampus (Figure 7) . No significant effects were observed by two-way ANOVA when comparing SH and EE WT and PLC-b1 KO mice as observed in the CPu (F (1, 20) = 0.458, P = 0.507 for genotype, and F (1, 20) = 3.497, P = 0.078 for environment), the hippocampus (F (1, 20) = 4.013, P = 0.059 for genotype, and F (1, 20) = 0.038, P = 0.847 for environment) and in the cortex (F (1, 20) = 3.922, P = 0.064 for genotype, and F (1, 20) = 0.129, P = 0.724 for environment).
Discussion
The present study shows that disruption of PLC-b1 mediated signaling results in behavioral abnormalities including decreased startle response, PPI deficits, locomotor hyperactivity and impaired spatial memory. Environmental enrichment had a positive effect upon the motor and sensorimotor behavior of the mutant mice, but did not exert a beneficial effect upon their MWM performance, a dissociation which may suggest that the aberrant phenotype caused by the PLC-b1 null mutation is mediated by distinct pathways differentially responsive to the effects of enrichment. Alternatively, given the dissociation we observe in the effects of environmental enrichment, it is of significant interest that learning and memory are particularly susceptible to dorsal hippocampal manipulations, 42, 43 while locomotor activity and PPI, which are modulated, but not mediated, by the hippocampus (in that its involvement is not critical to performance of the behavior), have been shown to be much more susceptible to ventral hippocampal lesions. 44 Environmental enrichment may be regionally specific, providing another potential explanation for the discrepancy in the enrichment effect; however, further experiments would be required in order to resolve this question.
At a molecular level, disrupting the PLC-b1 signaling pathways resulted in decreased [ [45] [46] [47] In addition, PLC-b1 KO mice have been shown to have aberrant changes in the cortex and hippocampus during development and in the adult 3, 9, [27] [28] [29] 48 to which [ would suggest that PLC-b1 KO mice have decreased muscarinic M1 receptors in the cortex and muscarinic M1/M4 receptors in the hippocampus. Significantly, our data suggest that enrichment rescues these receptor levels in PLC-b1 KO mice without impacting upon receptor density in wild types. Notably, PLC-b1 KO and subsequent environmental enrichment does not globally affect G protein-coupled receptors per se, as the densities of the 5-HT 2A receptor and the D2 receptor were not altered in PLC-b1 KO mice under any condition; however it is possible that changes may occur in other receptors which have not yet been assessed. Our data nonetheless suggest that the locomotor and/or PPI disruption, and subsequent rescue, seen in the PLC-b1 KO mice may be a result of altered M1 levels in these animals.
Previous studies investigating the behavioral effects of muscarinic signaling are consistent with our results. Nonselective muscarinic receptor antagonists such as scopolamine, trihexyphenidyl and benztropine have been shown to disrupt PPI 49, 50 suggesting that a generalized inhibition of muscarinic signaling, as is present in our mice, is sufficient for disruption of PPI behavior. Furthermore, M1 receptor KO mice display locomotor hyperactivity and reduced freezing under SH conditions. 51 In summary, We propose that the attenuation of phosphoinositide hydrolysis due to the absence of PLC-b1 and feedback mechanisms regulating plasticity of muscarinic receptor expression in the adult neocortex may be responsible for the reduction of pirenzepine binding in standard housed KO animals. Muscarinic signaling has been demonstrated to modulate, and to be modulated by, other signaling systems, including dopaminergic 52 and GABAergic pathways. [53] [54] [55] More specifically, the observed phenotypes may be elicited as a result of decreased M1 receptor expression mediating an increase in striatal extracellular dopamine, as observed in the M1 KO mouse, 53 resulting in the impaired motor and sensorimotor phenotype recorded for these animals. This must clearly be distinguished from altered receptor binding as we have shown no difference between WT and KO mice D2 receptor in the striatum. Furthermore, decreased potentiation of GABAergic signaling in the prefrontal cortex 54 resulting in neuronal hyperexcitability may also be contributing to this phenotype of hyperactivity and disrupted PPI.
Interestingly, imbalances between the muscarinic cholinergic and the dopaminergic systems, and abnormal hippocampal activity have been postulated to play an important role in the underlying pathophysiology of schizophrenia. Based on this concept, the sensorimotor gating behavioral deficit in PLC-b1 KO mice was rescued by the atypical antipsychotic clozapine, but not haloperidol (a typical antipsychotic). Haloperidol is a potent dopamine D2-like receptor and sigma receptor antagonist with a low affinity for a-adrenergic and 5-HT 2A receptors. 56, 57 By contrast, clozapine is the archetypal atypical antipsychotic that treats a broader range of symptoms in Figure 4 Prepulse inhibition in phospholipase C-b1 knockout (PLC-b1 KO) mice under different environmental and pharmacological conditions. Significant effects of genotype (main effect of genotype P < 0.001), environment (main effect of environment P < 0.001) and prepulse (main effect of prepulse P < 0.001 in sensorimotor gating behavior) were observed (a). Interactions between these factors also reached significance (genotype Â environment interaction P < 0.05 and genotype Â environment Â prepulse P < 0.05). Pairwise t-tests revealed significant prepulse inhibition (PPI) deficits in PLC-b1 KO mice at PP8 (P < 0.01) with trends toward significance at PP4 (P = 0.067) and PP16 (P = 0.082). This deficit was rescued by environmental enrichment at PP8 (P < 0.001) and PP16 (P < 0.05) but not PP4 (only average PPI displayed here). No significant effect of environment was observed for wild-type (WT) mice. Saline-injected KO mice display a deficit relative to saline-injected littermates (main effect of genotype P < 0.05). Both haloperidol (HAL) (b) and clozapine (CLOZ) (c) had significant effects upon sensorimotor gating (main effect of HAL P < 0.01 and main effect of CLOZ P < 0.01). Interestingly, a genotype Â clozapine Â prepulse interaction was evident (P < 0.05). Pairwise comparisons indicate a significantly lower level of sensorimotor gating in HAL-treated KO mice in comparison to HAL-treated WT (P < 0.01 at PP4 and P < 0.05 at PP8 and PP16). Clozapine had a significant effect upon PPI of WT mice at PP4 and PP8 (P < 0.01) and significantly rescued KO PPI at PP8 (P < 0.05).
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Dentate Gyrus Striatum H]pirenzepine binding was performed in wild-type (WT) and KO standard housed (SH) and environmentally enriched mice. Selection of brain regions for analysis was dependent upon our ability to accurately delineate their boundaries based upon the strength of the binding pattern (represented graphically with a WTSH coronal section). Cortex, striatum and the CA1 and dentate gyrus (DG) of the hippocampus were assessed (a). Significant genotype Â environment interactions were seen for [ 3 H]pirenzepine binding to M1/M4 receptors, as measured by autoradiography, in the cortex (b; P < 0.05), CA1 (c; P < 0.05) and the DG (d; P < 0.05). Binding was significantly lower in the cortex and DG of KO SH animals when compared with their WT SH littermates (P < 0.05). This deficit was reversed by EE in the DG (c; P < 0.05) with a trend toward reversal in the cortex (b; P = 0.07). Enrichment also significantly affected the levels of binding in the CA1 of KO animals (c; P < 0.01). No effects of enrichment were observed in the WT mice. Interestingly, no changes in binding were observed in the striatum across all groups (e). *P < 0.05. subjects with schizophrenia and has a complex pharmacology. Clozapine binds with high affinity to D4, 5-HT 1A, 2A , a1 adrenergic, histamine H1 and muscarinic receptors, and with lower affinity for D1, D2, D3 and D5 receptors. [58] [59] [60] [61] [62] While the significant effect of haloperidol upon PPI, independent of genotype, is consistent with previous studies, 63 clozapine mediated a complete rescue of PPI deficits in the KO mice. Thus, at the level of PPI behavior, environmental enrichment is acting in a parallel manner to clozapine, an atypical antipsychotic drug with clinical efficiency. However, as PPI is affected by many neurotransmitter pathways 64 it is not yet possible to predict which pathways may be common between the effects of environmental enrichment and clozapine.
To date, animal modeling of schizophrenia has primarily consisted of pharmacological manipulation, and has provided invaluable information as to the efficacy of antipsychotic drugs in the treatment of schizophrenia. The models generally reproduce two endophenotypes, namely locomotor hyperactivity and sensorimotor gating deficits; [65] [66] [67] and while their practical use in validating novel medications is clear, pharmacological models are somewhat limited with respect to construct validity. Genetic modification has advantages over pharmacological models as it is developmental in nature, can be differentially affected by environmental components, is more femtomole/mg ETE femtomole/mg ETE Figure 6 [ 3 H]ketanserin binding in phospholipase C-b1 knockout (PLC-b1 KO) mice and the effects of environmental enrichment. Regions for analysis following ketanserin binding were again chosen based on our ability to delineate the structures (represented by a WTSH coronal section; a). A laminar binding pattern was observed in the cortex and so the cortex was analyzed as layers 2/3 (b), layer 4 (c) and layer 5/6 (d). Binding throughout the hippocampus was uniform and as such it was assessed as a whole (e). We also analyzed the striatum (f) in wild-type (WT) and KO standard housed (SH) and environmentally enriched (EE) mice. Two-way analysis of variance revealed no significant differences between groups, either by genotype or by housing conditions, despite an apparent trend toward decreased [ 3 H]ketanserin binding in the KO SH mice, returned to WT levels following enrichment. 3 H]YM-09151 binding in phospholipase C-b1 (PLC-b1 KO) mice and the effects of environmental enrichment. [ 3 H]YM-09151 binding was very strong in the striatum, and was also observed at low levels on the cortex and the hippocampus (a; schematic and WTSH coronal section) in wild-type (WT) and PLC-b1 KO standard housed (SH) and environmentally enriched (EE) mice. No significant differences were detected by two-way analysis of variance, neither by genotype nor by environment, within the cortex (b), hippocampus (c) and striatum (d) of PLC-b1 KO and WT standard housed and environmentally enriched animals. specific in its targets and, in this manner, more accurately represents a human disease state. PLC-b1 has been shown to have altered expression in schizophrenic individuals. 26 Moreover, the PLC-b1 null mutation disrupts signaling through multiple pathways implicated in schizophrenic pathogenesis, such as the muscarinic cholinergic pathways, resulting in a comprehensive behavioral phenotype which correlates with that observed in the human condition. [68] [69] [70] [71] [72] We show that this mouse model exhibits numerous endophenotypes characteristic of schizophrenia including locomotor hyperactivity, sensorimotor gating deficits and cognitive deficits. The beneficial effects of the antipsychotic treatment on PPI suggest that the model has predictive validity. The profound effect of environmental enrichment, including rescue or complete reversal of behavioral disruption, illustrates the importance of environmental factors in modulating genetic effects. Modeling genetic and environmental factors as well as their associated gene-environment interactions will provide crucial insights into the pathogenesis of schizophrenia and related brain disorders.
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